This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://sfbn.org/san-francisco-biotech-news/2025/10/19/rapt-therapeutics-to-report-topline-data-from-phase-2-clinical-trial-of-rpt904-in-chronic-spontaneous-urticaria-csu/?utm_source=rss&utm_medium=rss&utm_campaign=rapt-therapeutics-to-report-topline-data-from-phase-2-clinical-trial-of-rpt904-in-chronic-spontaneous-urticaria-csu